Related Experiment Video
Updated: Oct 1, 2026

Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
Published on: July 6, 2014
Cyclic thrombocytopenia related to menstrual cycle: a case report and literature review
Guoshu Chen1, Li Chen1, Xiaohua Qin1
1Department of Hematology, Huizhou Municipal Central Hospital 41, Eling Road North, Huizhou 516001, PR China.
Abstract:
Cyclic thrombocytopenia (CTP) is rarely seen and characterized by periodic fluctuations in platelet counts. In some cases, it occurs in phase with menstrual cycle. A 40-year-old female, presented firstly on June 30, 2012, with a 40-day history of appearance of purpuric skin rash and bruising, was readmitted on Aug 14, when she noted bruise on her lips. The platelet count was 24×10(9)/L on June 30, 32×10(9)/L on Aug 14, while it was 161×10(9)/L on July 1, 110×10(9)/L on Aug 16. Physical examination show skin purpuric spots and bruise over the limbs and truck. Liver, spleen, lymph nodes were not enlarged. Antinuclear antibody and rheumatoid factor (RF) were positive. Results of immune complex levels, serum complements, Hp antibody and Thrombopoietin (TPO) were all within normal ranges. Bone marrow aspiration and biopsy shown there was no change in megakaryocyte number. Fluorescence-activated cell sorter (FACS) performed normal. JAK2-V617F gene mutational and platelet-associated antibodies were not detected. We observed the patient over two complete cycles, and continued investigating her blood counts for six months follow up. During the entire process, her menstrual was regular without heavy blood loss and prolonged period. Her hemoglobin and white cell counts remained normal without cyclic change. Even if the patient was not on any therapy designed to increase the platelet count, her platelet level was back to normal. Follow up to December, 2012; her platelet count continued to fluctuation, 20×10(9)/L-40×10(9)/L in the middle of menstrual cycle while 105×10(9)/L-197×10(9)/L at the menses.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Venous Thrombosis I: Introduction

